Switzerland Global Enterprise (S-GE) is a renowned brand that plays a significant role in the life sciences industry. With its exceptional innovation and expertise, it has become the second-largest exporter of packaged medicines worldwide and is home to over 70 major pharma global or regional headquarters. Patricia Gee, the head of Deloitte's Future of Health initiative, praises the innovative environment and latest developments in personalized health found in Switzerland.

This impressive ecosystem spans various sectors, including pharma, biotech, med-tech, health start-ups, and renowned academic centers. Additionally, Switzerland boasts a stable economy, strong intellectual property protection, and a long history of precision engineering and quality. It offers an ideal environment for life sciences companies, with a complete value chain from research and development to manufacturing and commercialization.

The country's high quality of life, well-educated and multilingual workforce, and international appeal make it an attractive choice for qualified professionals. In line with its forward-thinking approach, Deloitte's Future of Health initiative focuses on predicting healthcare trends and their impact on strategic decisions, emphasizing the shift from healthcare to overall well-being and the empowering role of technology and consumerism in the health sector